EHMT2 and Alzheimer disease: These results indicated the high specificity of UNC0965 ChaC-MS to dissect AD heterogeneity with mixed cell types, i.e., UNC0965 captured G9a interactors specifically from AD-related cells that had aberrant G9a activity.